Insulin and oral hypoglycemic agents should not be used in combination in the treatment of type 2 diabetes

Arch Intern Med. 2003 Aug;163(15):1783-5; discussion 1785. doi: 10.1001/archinte.163.15.1783.

Authors

Sydney A Westphal¹, Pasquale J Palumbo

Affiliation

¹ Departments of Medicine, Maricopa Medical Center, Phoenix, Ariz, USA. sydney.westphal@hcs.maricopa.gov

PMID: 12912711
DOI: 10.1001/archinte.163.15.1783

No abstract available

MeSH terms

Administration, Oral
C-Peptide / blood
Diabetes Mellitus, Type 2 / blood
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / physiopathology
Drug Therapy, Combination
Humans
Hypoglycemia / chemically induced
Hypoglycemic Agents / administration & dosage*
Hypoglycemic Agents / adverse effects
Insulin / administration & dosage*
Insulin / adverse effects
Insulin / blood
Weight Gain / drug effects

Substances

C-Peptide
Hypoglycemic Agents
Insulin